Defense Advanced Research Projects Agency (DARPA), Contracts Management Office (CMO), 3701 N. Fairfax Dr., Arlington, VA 22203-1714

A -- BIOLOGICAL WARFARE DEFENSE (BWD), PATHOGEN COUNTERMEASURES (PC) SOL Sole Source 98-12 POC Alan Frederick, PCO, DARPA/CMD (E-mail: afrederick@darpa.mil) The Defense Advanced Research Projects Agency (DARPA) intends to modify Contract MDA972-96-K-0002 with Boston University, Boston, MA, for the purpose of continuing research and development (R&D) relative to arming red blood cells in support of DARPA's BWD/PC Program; specifically, the development of protective enzymes for red blood cells. This institution is the only source known to the Government that possesses the requisite capabilities, facilities and experiences, and that can accomplish this R&D within the Government's cost and schedule constraints. The estimated value of this effort is under $1 million; the estimated duration is approximately twelve months. This Notice is not a request for proposals. See note number 22. (0133)

Loren Data Corp. http://www.ld.com (SYN# 0006 19980515\A-0006.SOL)